Rifabutin Suppresses Inducible Clarithromycin Resistance in

NTM clarithromycin erm41 non-tuberculous mycobacteria rifabutin synergy whiB7

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
10 Feb 2020
Historique:
received: 21 12 2019
revised: 23 01 2020
accepted: 06 02 2020
entrez: 14 2 2020
pubmed: 14 2 2020
medline: 14 2 2020
Statut: epublish

Résumé

Clarithromycin (CLR) is the corner stone in regimens for the treatment of lung disease caused by

Identifiants

pubmed: 32050554
pii: antibiotics9020072
doi: 10.3390/antibiotics9020072
pmc: PMC7168051
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI132374
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142731
Pays : United States
Organisme : NIH HHS
ID : R01AI132374
Pays : United States
Organisme : NIH HHS
ID : U19AI142731
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Diagn Microbiol Infect Dis. 1993 May-Jun;16(4):343-9
pubmed: 8495592
Am J Respir Crit Care Med. 2012 Nov 1;186(9):917-25
pubmed: 22878281
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28396540
Antimicrob Agents Chemother. 2009 Apr;53(4):1367-76
pubmed: 19171799
Expert Opin Drug Discov. 2019 Sep;14(9):867-878
pubmed: 31195849
Antimicrob Agents Chemother. 2020 Jan 27;64(2):
pubmed: 31767722
Antimicrob Agents Chemother. 2011 Feb;55(2):775-81
pubmed: 21135185
Int J Syst Evol Microbiol. 2016 Nov;66(11):4471-4479
pubmed: 27499141
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30670428
Emerg Infect Dis. 2015 Sep;21(9):1638-46
pubmed: 26295364
J Antimicrob Chemother. 2014 Jun;69(6):1559-63
pubmed: 24500188
J Clin Microbiol. 2015 Apr;53(4):1211-5
pubmed: 25653399
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28874379
Front Microbiol. 2018 Sep 12;9:2179
pubmed: 30258428
Antimicrob Agents Chemother. 2020 Jan 27;64(2):
pubmed: 31791943
Future Microbiol. 2019 Jun;14:749-755
pubmed: 31271060
Drug Discov Today. 2018 Aug;23(8):1502-1519
pubmed: 29635026
Front Microbiol. 2019 Aug 23;10:1977
pubmed: 31507579
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
pubmed: 17277290
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28874378
Microorganisms. 2019 Mar 22;7(3):
pubmed: 30909391
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29760147
Front Microbiol. 2018 May 11;9:932
pubmed: 29867841
Clin Infect Dis. 2017 Feb 1;64(3):309-316
pubmed: 28011608
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64
pubmed: 29054853

Auteurs

Dinah Binte Aziz (DB)

Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.

Mei Lin Go (ML)

Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore.

Thomas Dick (T)

Department of Medical Sciences, Hackensack Meridian School of Medicine at Seton Hall University, 340 Kingsland Street, Nutley, NJ 07110, USA.
Center for Discovery and Innovation, Hackensack Meridian Health, 340 Kingsland Street Building 102, Nutley, NJ 07110, USA.

Classifications MeSH